SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is experiencing a surge in investor interest fueled by a strong revenue beat and strategic pivots toward industrial-scale photonics and AI hardware. The community remains highly active in debating the stock's potential for a parabolic short squeeze, closely monitoring institutional accumulation and recent technological deployment milestones.

Kopin Corp. engages in the development, manufacture and sale of wearable technologies which include components and systems. Its portfolio includes AMLCD, LCOS displays, OLED displays, ASIC, backlights, and optical lenses. The firm uses semiconductor material technology to design, manufacture and market its component products for use in military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. The company was founded by John C.C. Fan on April 23, 1984 and is headquartered in Westborough, MA.

Kopin Corp.

Kopin Corp

Kopin Corp is surging following a new multi-million dollar defense contract and strong community buzz surrounding its pivot into AI-driven optical interconnect technology. Investors are actively tracking the stock's move toward higher price levels as they discuss its potential role in addressing data center power bottlenecks alongside the broader AI infrastructure market.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh strong earnings and significantly raised EBITDA guidance against ongoing geopolitical instability in the Strait of Hormuz. While some community members remain frustrated by price volatility and perceived market manipulation, others are aggressively accumulating shares, viewing the company as a long-term play on rising global LNG demand and supply chain constraints.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is experiencing high volatility as investors track rumors of a potential take-private bid by Trian Fund Management, fueling speculation about a short squeeze. The community is focused on the stock's long-term valuation, significant short interest, and international expansion plans as key catalysts to defend current levels.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing intense volatility as investors weigh conflicting narratives of aggressive hyperscaler infrastructure demand against concerns over valuation and capacity bottlenecks. The community remains deeply divided, with bulls pointing to the company's critical role in the AI data center optical upgrade cycle while bears caution that the stock's parabolic ascent and historical lack of consistent profitability signal a potential correction.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is trending due to significant momentum from positive preclinical data on its ovarian cancer treatment, which has ignited a battle between aggressive bulls targeting a breakout and skeptics focused on the company's dilution history. The community is closely watching the stock's low float and high short interest, with many traders anticipating a potential squeeze while others express caution regarding the long timeline for human clinical trials.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is at the center of heated community debate as investors weigh the company's recent achievement of closing Phase 3 of the FAA's type certification process against persistent concerns regarding cash burn and the timeline for piloted transition flights. While supporters point to strong strategic partnerships and regulatory progress as proof of a viable commercial future, critics remain focused on production speed and transparency, creating a volatile environment where sentiment shifts rapidly ahead of upcoming earnings.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark shares are experiencing heightened volatility as the community debates the timing of an anticipated AI infrastructure deal and its shift toward high-performance computing. While some investors are bullish on the company's power capacity and Bitcoin treasury as long-term catalysts, others are expressing frustration over the lack of a concrete hyperscale contract and the impact of recent quarterly earnings.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense retail momentum as traders draw parallels between its specialized memory chips and the massive growth seen in major semiconductor stocks. The community is actively discussing a potential gamma squeeze driven by high call option interest and the company's perceived role as a critical infrastructure player for AI and defense.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund is experiencing extreme volatility and intense community debate as investors grapple with the significant premium over its underlying net asset value. While bulls focus on the fund's direct exposure to high-growth AI and tech giants like Anthropic and SpaceX, bears and critics are actively highlighting potential concerns regarding lock-up expirations, structural sell-offs by insiders, and the risks inherent in its private-market valuation model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates

Coherus Oncology (CHRS) delivered earnings and revenue surprises of -38.89% and -14.37%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +93.35% and +16.63%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates

Geron (GERN) delivered earnings and revenue surprises of +60.00% and +2.94%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Biorestorative Therapies (BRTX) Looks Ripe for Bottom Fishing

Biorestorative Therapies (BRTX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

BioRestorative Therapies (OTCMKTS:BRTXQ) Trading 5.7% Higher - Here's Why

BioRestorative Therapies (OTCMKTS:BRTXQ) Trading 5.7% Higher - What's Next...

BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 4.5%  - Here's What Happened

BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 4.5% - What's Next...

Biorestorative Therapies, Inc. (BRTX) Reports Q4 Loss, Lags Revenue Estimates

Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of +13.51% and -90.20%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue Estimates

ABSCI CORP (ABSI) delivered earnings and revenue surprises of -40.24% and -82.15%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -58.33% and +4.22%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates

Monte Rosa Therapeutics (GLUE) delivered earnings and revenue surprises of -17.02% and -72.90%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.

BRTX
BioRestorative Therapies Inc

Feed

News

Sentiment

Fundamentals

Info

Historical Earnings

Latest BRTX News

BRTXBioRestorative Therapies Inc